Breast Cancer Treatment Is Reduced To 1 Week
Mary Hospital will offer a new clinical study by Xoft using electronic brachytherapy for the treatment of early stage breast cancer.
|
PeregrineInitiates Clinical Trial Of Bavituximab In Patients With Advanced Breast Cancer
Peregrine Pharmaceuticals has begun patient screening in a clinical trial designed to evaluate the safety and efficacy of bavituximab in combination with chemotherapy in patients with advanced breast cancer.
|
Peregrine To Conduct Trial Of Bavituximab In Patients With Advanced Breast Cancer
Peregrine Pharmaceuticals's Phase II clinical protocol to study bavituximab in combination with chemotherapy in patients with advanced breast cancer has been approved by DCGI.
|
Copayments Reduce Likelihood Women Will Receive Regular Mammograms
A copayment of $12.50 to $35 reduces by 8.3 percentage points the likelihood that women will receive regular mammograms to detect breast cancer.
|
New Pathway Provides More Clues About BRCA1 Role In Breast Cancer
A breast cancer gene's newly discovered role in repairing damaged DNA may help explain why women who inherit a mutated copy of the gene are at increased risk for developing both breast and ovarian cancer.
|
Voters Support Raising Taxes To Fight Breast Cancer
Survey shows that nearly sixty percent of voters are willing to raise taxes to ensure all women have access to quality breast cancer screening and treatment.
|
Improving Breast Cancer Treatment At Cardiff
Cardiff University research could improve breast cancer treatment for women who become resistant to drugs such as tamoxifen.
|
Small RNAs Can Prevent Spread Of Breast Cancer
Researchers have identified small pieces of ribonucleic acid (RNA) that suppress the spread of breast cancer to the lungs and bone.
|
Kosan Initiates Trial Of Alvespimycin In HER2-Positive Metastatic Breast Cancer
Kosan Biosciences initiates Phase 2 trial of alvespimycin, the company's second-generation Hsp90 inhibitor, in patients with HER2-positive metastatic breast cancer.
|
FDA Approves New Genetic Test For Breast Cancer Patients
FDA has approved a test that helps in assessing the risk of tumor recurrence and long-term survival for patients with relatively high-risk breast cancer.
|
Inaccurate Lab Tests Might Lead To Wrong Treatment of Breast Cancer
Thousands of breast cancer patients might receive improper medications as a result of inaccurate results for two laboratory tests used to determine the most effective treatments for specific patients.
|
Bevacizumab Improves Survival For Patients With Advanced Breast Cancer
Inhibiting the growth of blood vessels that supply tumors slows the progression of metastatic breast cancer according to results of a large clinical trial of Avastin, an anti-angiogenic therapy.
|
Most Breast Cancer Surgeons Don't Talk About Reconstruction Options
Only a third of patients with breast cancer discussed breast reconstruction options with their surgeon before their initial surgery.
|
Breast Cancer More Prevalent In Hispanic Women
Hispanic women have the highest prevalence of the cancer-associated gene mutation BRCA1 at 3.5 percent, with Asian Americans having the lowest prevalence.
|
Reconstruction surgery rarely discussed with breast cancer patients
To be educated consumers of healthcare and ensure maximal breast cancer treatment decision quality the patients should be informed of all breast cancer treatment options. Most general surgeons do not discuss reconstruction with patients before surgical breast cancer treatment.
|
Morgan Pressel To Fund Breast Cancer Research In A Charity Event
LPGA Tour phenom Morgan Pressel announced the formation of the Morgan and Friends Fight Cancer Tournament in Boca Raton to fund research on breast cancer.
|
Drug Combination Shrinks Breast Cancer Metastases In Brain
A combination of a targeted therapy and chemotherapy shrank metastatic brain tumors by at least 50 percent in one-fifth of patients with aggressive HER2-positive breast cancer.
|
Results From Breast Cancer Trials Herald Hope For Thousands Of Women
New data from ATAC, one of the world's largest and longest-running studies in postmenopausal women with early breast cancer, reinforce that anastrozole can help many more women live cancer-free, for longer.
|
A 'Must Read' For Breast Cancer Patients
Patent 7,309,486 issued to NexGen Biomedical discloses a better way of using Genentech's drug Herceptin against breast cancer.
|
BSGI Is A Strong Adjunct Imaging Modality To Mammography, Ultrasound
Study demonstrated the value of Breast-Specific Gamma Imaging (BSGI) as a strong adjunctive imaging modality to mammography and breast ultrasound.
|
Drug Combination Shrinks Breast Cancer Metastases In Brain
A combination of a targeted therapy and chemotherapy shrank metastatic brain tumors by at least 50 percent in one-fifth of patients with aggressive HER2-positive breast cancer.
|
Study Opens The Door For Avastin Use In Women With Breast Cancer
Avastin (bevacizumab) can proceed to be tested after breast cancer surgery in combination with anthracycline containing regimens.
|
Study Supports PreMD's Breast Cancer Detection Technology
PreMD data shows increased reactivity in nipple aspirate fluid from breast cancer patients.
|
Surgical Treatment On Breast Asymmetry Improves Quality Of Life
Study suggests that surgical treatment for breast asymmetry (disproportionate breast size) provides an improvement in the quality of life and self-esteem of patients.
|
Researchers identify and repress breast cancer stem cells in mouse tissue
By manipulating highly specific gene-regulating molecules called microRNAs, scientists at Cold Spring Harbor Laboratory (CSHL) report that they have succeeded in singling out and repressing stem-like cells in mouse breast tissue - cells that are widely thought to give rise to breast cancer.
|
Survival Shortened When ER/PR Negative Breast Cancer Spreads to the Brain
Two studies from Mayo Clinic's site in Jacksonville, Fla., of women whose breast cancer spread to their brain, have found that women whose tumors do not have estrogen or progesterone receptors have the worst overall outcomes.
|
Even Tiny Breast Tumors Can Be Aggressive and May Require Maximum Therapy
Breast tumors that are 1 centimeter in size or smaller - no more than 0.4 inch in length - can still be very aggressive and may require more intensive therapy than is routinely offered today
|
MammaPrint Breast Cancer Test Shown To Be Powerful Tool
Agendia BV's MammaPrint breast cancer prognosis test was shown to be a valuable tool to assess risk of breast cancer recurrence also in post menopausal breast cancer patients.
|
Tykerb combination reduced brain tumours linked to HER2-positive breast cancer
GlaxoSmithKline announces data on Tykerb (lapatinib) plus capecitabine for the treatment of HER2-positive breast cancer brain metastases.
|
Denosumab Increased Bone Density in Certain Breast Cancer Patients
Pivotal Phase 3 data show Denosumab increased bone density throughout skeleton in non-Metastatic Breast Cancer patients on adjuvant aromatase inhibitor therapy.
|
Anastrozole Confirmed Superior In Breast Cancer Prevention
Anastrozole is more effective than tamoxifen at preventing breast cancer recurrence for periods of at least 10 years in women with hormone-responsive cancers.
|
Despite Early Breast Cancer Signs Test Predicts Who Could Avoid Chemotherapy
New data shows for the first time the predictive value of the 21-gene Recurrence Score (RS) assay in patients with node-positive breast cancer.
|
Importance of emotional needs among women with advanced breast cancer
Survey data also underscores dissatisfaction with breast cancer treatment experience, importance of internet as informational resource.
|
HERmark Presents Assay Results In Metastatic Breast Cancer
Monogram Biosciences presented the results of a study detailing the HERmark Assay's ability to identify metastatic breast cancer patients who are most likely to respond to Herceptin.
|
MammaPrint Breast Cancer Test Provides Benefits To Patients From Personalized Treatment Regimen
MammaPrint breast cancer prognosis test was successfully implemented in the diagnostic process of breast cancer patients in community hospitals in The Netherlands.
|
Taxotere-Based Chemotherapy Significantly Improved Overall Survival Compared In Breast Cancer
For women with early stage breast cancer treatment with the investigational chemotherapy combination of Taxotere Injection Concentrate and cyclophosphamide significantly improved overall survival.
|
Agendia's Breast Cancer Prognosis Test Is Now Available In US
Agendia makes its breast cancer prognosis test, MammaPrint, available to US patients.
|
Minority Women Should Sign Up For Study Looking At Breast Cancer
Black women are not showing up for mammograms early and often enough, which contributes to a higher incidence of breast cancer and mortality rate from the disease.
|
Breast MRI spots other cancers, may alter treatment plan
MRI, which is not routinely administered to these patients, can find additional cancerous areas in the breast that previously evaded detection, discover cancer in the opposite breast that standard imaging tests such as mammography and ultrasound missed, or determine a tumor is actually larger than expected, the doctors say.
|
FDA Says Breast Cancer Treatment Avastin Needs Further Study
Breast cancer treatment drug Avastin does not appear to extend overall survival of breast-cancer patients and FDA will ask outside medical panel if Genentech's Avastin should be approved for breast cancer treatment.
|
